Atrás
Rango del Día
$122.27
$126.67
Rango de 52 Semanas
$68.70
$155.53
Volumen
1,028,731
Promedio 50D / 200D
$131.49
/
$113.06
Cierre Anterior
$123.79
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 22.7 | 0.4 |
| P/B | 7.1 | 2.9 |
| ROE % | 33.4 | 3.7 |
| Net Margin % | 19.6 | 3.9 |
| Rev Growth 5Y % | -1.0 | 10.0 |
| D/E | 0.9 | 0.2 |
Precio Objetivo de Analistas
Hold
$147.13
+16.8%
Low: $110.00
High: $170.00
P/E Futuro
24.1
EPS Futuro
$5.13
Crecimiento EPS (est.)
+0.0%
Ingresos Est.
4.5 B
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$8.23
$8.07 – $8.36
|
5.7 B | 2 |
| FY2029 |
$7.53
$7.39 – $7.65
|
5.4 B | 2 |
| FY2028 |
$6.65
$6.24 – $7.60
|
5.1 B | 6 |
Puntos Clave
Revenue declined -1.03% annually over 5 years
ROE of 33.36% indicates high profitability
Net margin of 19.58% shows strong profitability
Generating 931.00M in free cash flow
Cash machine — converts 109.53% of earnings into free cash flow
Capital efficient — spends only 3.41% of revenue on capex
Crecimiento
Revenue Growth (5Y)
-1.03%
Revenue (1Y)-0.69%
Earnings (1Y)N/A
FCF Growth (3Y)81.70%
Calidad
Return on Equity
33.36%
ROIC12.30%
Net Margin19.58%
Op. Margin19.92%
Seguridad
Debt / Equity
0.94
Current Ratio2.08
Interest Coverage8.65
Valoración
P/E Ratio
22.66
P/B Ratio7.07
EV/EBITDA23.58
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -0.69% | Revenue Growth (3Y) | -1.81% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -1.03% | Earnings Growth (5Y) | 2.77% |
| Profitability | |||
| Revenue (TTM) | 4.34B | Net Income (TTM) | 850.00M |
| ROE | 33.36% | ROA | 12.79% |
| Gross Margin | 66.49% | Operating Margin | 19.92% |
| Net Margin | 19.58% | Free Cash Flow (TTM) | 931.00M |
| ROIC | 12.30% | FCF Growth (3Y) | 81.70% |
| Safety | |||
| Debt / Equity | 0.94 | Current Ratio | 2.08 |
| Interest Coverage | 8.65 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 22.66 | P/B Ratio | 7.07 |
| P/S Ratio | 4.44 | PEG Ratio | -0.14 |
| EV/EBITDA | 23.58 | Dividend Yield | 0.00% |
| Market Cap | 19.26B | Enterprise Value | 20.40B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 4.34B | 4.37B | 4.50B | 4.58B | 4.53B |
| Net Income | 850.00M | -1.22B | -1.16B | -4.40B | 762.00M |
| EPS (Diluted) | 5.44 | -7.69 | -7.35 | -28.05 | 5.05 |
| Gross Profit | 2.89B | 2.86B | 2.74B | 2.97B | 3.15B |
| Operating Income | 865.00M | -833.00M | -1.07B | -4.18B | -123.00M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 6.64B | 6.30B | 10.11B | 12.25B | 15.22B |
| Total Liabilities | 3.92B | 3.93B | 4.37B | 5.65B | 4.48B |
| Shareholders' Equity | 2.72B | 2.37B | 5.75B | 6.60B | 10.74B |
| Total Debt | 2.55B | 2.62B | 2.26B | 3.56B | 2.54B |
| Cash & Equivalents | 1.42B | 1.13B | 1.05B | 2.01B | 1.23B |
| Current Assets | 3.29B | 2.75B | 2.61B | 3.56B | 2.71B |
| Current Liabilities | 1.59B | 1.55B | 1.57B | 2.77B | 1.09B |